Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections

Kerry Dobbs(Inserm), Cecilia Domínguez Conde(Austrian Academy of Sciences), Shen‐Ying Zhang(Institut des Maladies Génétiques Imagine), Silvia Parolini(University of Brescia), Magali Audry, Janet Chou(Boston Children's Museum), Emma Haapaniemi(University of Helsinki), Sevgi Keleş(Boston Children's Museum), Ivan Bilić(Austrian Academy of Sciences), Satoshi Okada, Michel J. Massaad(Boston Children's Hospital), Samuli Rounioja(Tampere University Hospital), Adel Alwahadneh, Nina K. Serwas(Austrian Academy of Sciences), Kelly Capuder(Boston Children's Hospital), Ergi̇n Çi̇ftçi̇(Ankara University), Kerstin Felgentreff(Boston Children's Museum), Toshiro K. Ohsumi(Massachusetts General Hospital), Vincent Pedergnana(Institut des Maladies Génétiques Imagine), Bertrand Boisson, Şule Haskoloğlu(Ankara University), Arzu Ensarı(Ankara University), Michael Schuster(Austrian Academy of Sciences), Alessandro Moretta(University of Genoa), Yuval Itan, Ornella Patrizi(Brescia University), Flore Rozenberg(Institut des Maladies Génétiques Imagine), Pierre Lebon(Institut des Maladies Génétiques Imagine), Janna Saarela(Institute for Molecular Medicine Finland), Mikael Knip(Tampere University Hospital), Slavé Petrovski(Duke University), David B. Goldstein(Columbia University), Roberta Parrott(Duke University), Berna Savaş(Ankara University), Axel Schambach(Medizinische Hochschule Hannover), Giovanna Tabellini(Brescia University), Christoph Bock(Austrian Academy of Sciences), Talal A. Chatila(Boston Children's Hospital), Anne Marie Comeau(University of Massachusetts Chan Medical School), Raif S. Geha(Boston Children's Hospital), Laurent Abel(Institut des Maladies Génétiques Imagine), Rebecca H. Buckley(Duke University), Aydan İkincioğulları(Ankara University), Waleed Al–Herz(Kuwait University), Merja Helminen(Tampere University Hospital), Figen Doğu(Ankara University), Jean‐Laurent Casanova(Hôpital Necker-Enfants Malades), Kaan Boztuǧ(Medical University of Vienna), Luigi D. Notarangelo(Harvard Stem Cell Institute)
New England Journal of Medicine
June 17, 2015
Cited by 199Open Access
Full Text

Abstract

Background Combined immunodeficiencies are marked by inborn errors of T-cell immunity in which the T cells that are present are quantitatively or functionally deficient. Impaired humoral immunity is also common. Patients have severe infections, autoimmunity, or both. The specific molecular, cellular, and clinical features of many types of combined immunodeficiencies remain unknown. Methods We performed genetic and cellular immunologic studies involving five unrelated children with early-onset invasive bacterial and viral infections, lymphopenia, and defective T-cell, B-cell, and natural killer (NK)-cell responses. Two patients died early in childhood; after allogeneic hematopoietic stem-cell transplantation, the other three had normalization of T-cell function and clinical improvement. Results We identified biallelic mutations in the dedicator of cytokinesis 2 gene (DOCK2) in these five patients. RAC1 activation was impaired in the T cells. Chemokine-induced migration and actin polymerization were defective in the T cells, B cells, and NK cells. NK-cell degranulation was also affected. Interferon-α and interferon-λ production by peripheral-blood mononuclear cells was diminished after viral infection. Moreover, in DOCK2-deficient fibroblasts, viral replication was increased and virus-induced cell death was enhanced; these conditions were normalized by treatment with interferon alfa-2b or after expression of wild-type DOCK2. Conclusions Autosomal recessive DOCK2 deficiency is a new mendelian disorder with pleiotropic defects of hematopoietic and nonhematopoietic immunity. Children with clinical features of combined immunodeficiencies, especially with early-onset, invasive infections, may have this condition. (Supported by the National Institutes of Health and others.).


Related Papers

No related papers found

Powered by citation graph analysis